CHRONIC GRAFT VERSUS HOST DISEASE AND PRETRANSPLANT DISEASE STATUS PREDICT OUTCOMES IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES UNDERGOING REDUCED INTENSITY ALLOGENEIC STEM CELL TRANSPLANTATION

被引：0
|
作者：
Shah, M. [1 ]
Agha, M. [1 ]
Mapara, M. [1 ]
Lenhart, K. [1 ]
Raptis, A. [1 ]
机构：
[1] Univ Pittsburgh, Sch Med, Pittsburgh Canc Inst, Pittsburgh, PA 15261 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2008年 / 14卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2007.12.333
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
323
引用
收藏
页码：119 / 119
页数：1
相关论文
共 50 条
  • [41] Mycophenolate mofetil and cyclosporine for graft-versus-host disease prophylaxis following reduced intensity conditioning allogeneic stem cell transplantation
    M Mohty
    H de Lavallade
    C Faucher
    K Bilger
    N Vey
    A-M Stoppa
    G Gravis
    D Coso
    P Viens
    J-A Gastaut
    D Blaise
    Bone Marrow Transplantation, 2004, 34 : 527 - 530
  • [42] Liver graft-versus-host disease after donor lymphocyte infusion for relapses of hematologic malignancies post allogeneic hematopoietic stem cell transplantation
    Ma, SY
    Au, WY
    Lie, AKW
    Ng, IO
    Leung, AYH
    Tse, EW
    Liang, RH
    Lau, GK
    Kwong, YL
    BONE MARROW TRANSPLANTATION, 2004, 34 (01) : 57 - 61
  • [43] Impact of total marrow/lymphoid irradiation dose to the intestine on graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for hematologic malignancies
    Saldi, Simonetta
    Fulcheri, Christian Paolo Luca
    Zucchetti, Claudio
    Abdelhamid, Amr Mohamed Hamed
    Carotti, Alessandra
    Pierini, Antonio
    Ruggeri, Loredana
    Tricarico, Sara
    Chiodi, Marino
    Ingrosso, Gianluca
    Bini, Vittorio
    Velardi, Andrea
    Martelli, Massimo Fabrizio
    Hui, Susanta Kumar
    Aristei, Cynthia
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [44] Liver graft-versus-host disease after donor lymphocyte infusion for relapses of hematologic malignancies post allogeneic hematopoietic stem cell transplantation
    S Y Ma
    W Y Au
    A K W Lie
    I OL Ng
    A Y H Leung
    E W Tse
    R H Liang
    G K Lau
    Y L Kwong
    Bone Marrow Transplantation, 2004, 34 : 57 - 61
  • [45] Co-morbidity Index, pretransplant disease status, graft-versus-host disease and fungal infections are the main outcome predictors after allogeneic stem cell transplantation using reduced-intensity conditioning regimens
    Patriarca, F.
    Sperotto, A.
    Battista, M. L.
    Toffoletti, E.
    Medeot, M.
    Simeone, E.
    Cerno, M.
    Geromin, A.
    Fanin, R.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S207 - S208
  • [46] Outcomes in Patients Age 70 or Older Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies
    Brunner, Andrew M.
    Kim, Haesook T.
    Coughlin, Erin
    Alyea, Edwin P., III
    Armand, Philippe
    Ballen, Karen K.
    Cutler, Corey
    Dey, Bimalangshu R.
    Glotzbecker, Brett
    Koreth, John
    McAfee, Steven L.
    Spitzer, Thomas R.
    Soiffer, Robert J.
    Antin, Joseph H.
    Ho, Vincent T.
    Chen, Yi-Bin
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (09) : 1374 - 1380
  • [47] Analysis of graft versus host disease and outcome in 100 patients undergoing allogeneic peripheral blood stem cell transplantation.
    Miflin, G
    Cook, G
    Franklin, I
    Morrison, A
    Green, R
    Hutchinson, RM
    Milligan, D
    Auer, R
    Potter, MN
    Morgan, GJ
    Pagliuca, A
    Marsh, J
    Bell, A
    Russell, NH
    BONE MARROW TRANSPLANTATION, 1998, 21 : S107 - S107
  • [48] The pretransplant systemic metabolic profile reflects a risk of acute graft versus host disease after allogeneic stem cell transplantation
    Reikvam, Hakon
    Hatfield, Kimberley
    Bruserud, Oystein
    METABOLOMICS, 2016, 12 (01) : 1 - 11
  • [49] Calcineurin inhibitor as graft versus host disease prophylaxis in patients with relapsed multiple myeloma undergoing allogeneic stem cell transplantation
    Posada Alcon, L.
    Calbacho Robles, M.
    Hernandez Perez, P.
    Ruiz Gomez, F. A.
    Chinea Rodriguez, A.
    Balerdi Malcorra, A.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S462 - S463
  • [50] The pretransplant systemic metabolic profile reflects a risk of acute graft versus host disease after allogeneic stem cell transplantation
    Håkon Reikvam
    Kimberley Hatfield
    Øystein Bruserud
    Metabolomics, 2016, 12
12345